Radspherin
Phase 1Active 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Peritoneal Carcinomatosis
Conditions
Peritoneal Carcinomatosis, Ovarian Cancer
Trial Timeline
Jun 8, 2020 → Aug 1, 2025
NCT ID
NCT03732768About Radspherin
Radspherin is a phase 1 stage product being developed by Oncoinvent for Peritoneal Carcinomatosis. The current trial status is active. This product is registered under clinical trial identifier NCT03732768. Target conditions include Peritoneal Carcinomatosis, Ovarian Cancer.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06504147 | Phase 2 | Recruiting |
| NCT03732768 | Phase 1 | Active |
| NCT03732781 | Phase 1/2 | Completed |
Competing Products
20 competing products in Peritoneal Carcinomatosis